Treatment of Outpatient Tracheitis in Adults

Antibiotic Selection

The European Respiratory Society recommends aminopenicillins, such as amoxicillin or amoxicillin-clavulanate, as first-line therapy for 5-7 days for outpatient management of bacterial tracheitis in adults without complicating factors 1, 3
For patients with risk factors for beta-lactamase producing organisms, the European Respiratory Society recommends amoxicillin-clavulanate as first-line therapy 2
Macrolides, such as azithromycin, and tetracyclines, such as doxycycline, are recommended as alternative options for penicillin-allergic patients 2
Oral cephalosporins are recommended for non-anaphylactic penicillin allergy 2
Respiratory fluoroquinolones are reserved for treatment failures or complicated cases 2, 4

The European Respiratory Society recommends hospital referral for patients with signs of respiratory distress, including respiratory rate ≥30 breaths/min, cyanosis, or blood pressure <90/60 mmHg 1
Patients with temperature <35°C or ≥40°C, heart rate ≥125 beats/min, altered mental status, confusion, or drowsiness should be referred to hospital 1
Suspected complications, such as pleural effusion or cavitation, and failure of initial outpatient antibiotic therapy are indications for hospital referral 1, 2

Sputum culture is recommended for patients with risk factors for potential severity, focal chest signs, or failure of initial empiric therapy 5
Blood tests, such as WBC and CRP, are not recommended for uncomplicated cases 5

The standard treatment duration for bacterial tracheitis is 5-7 days 2
Patients should be advised to return if fever does not resolve within 48 hours 2
Patients should be informed that cough may persist longer than the antibiotic treatment period 2

For patients with chronic lung disease, amoxicillin-clavulanate is recommended as first-line therapy due to the higher risk of beta-lactamase producing organisms 2, 6
Antibiotics are recommended for patients with COPD exacerbation and tracheitis when there is increased sputum purulence 6
Recent hospitalization, recent antibiotic use, severe underlying lung disease, and recent oral steroid use are risk factors for unusual or resistant organisms 6